Loading page
News of Bahrain
11 January 20222 min read

Bahrain updates precautionary quarantine protocol

Manama The Daily Tribune – www.newsofbahrain.com Following approval by the Government Executive Committee, and based on the latest international data and developments, the National Medical Taskforce for Combatting the Coronavirus (COVID-19) has highlighted that starti

Editorial Team Legacy

Published 11 January 2022, 8:00 · Updated 21:41

Link copied
Bahrain updates precautionary quarantine protocol

TDT | Manama

The Daily Tribune – www.newsofbahrain.com

Following approval by the Government Executive Committee, and based on the latest international data and developments, the National Medical Taskforce for Combatting the Coronavirus (COVID-19) has highlighted that starting from Thursday, 13 January 2022, the precautionary quarantine period will be seven days from the date of infection for individuals that hold a green shield on the BeAware Bahrain application.

Green shield holders can exit quarantine after seven days without taking a PCR test.

Individuals who are unvaccinated, or hold either a yellow or red shield on the BeAware Bahrain app, must quarantine for ten days from the date of infection and can exit quarantine after ten days without taking a PCR test.

The Taskforce also announced an update to the precautionary quarantine protocol for travellers entering the Kingdom of Bahrain through all ports of arrival. Individuals holding a yellow or red shield on the BeAware Bahrain app and unvaccinated travellers will need to quarantine on arrival for seven days. Travellers who hold a green shield on the BeAware Bahrain application are not required to quarantine.

The Taskforce stressed the importance of conducting a PCR test if experiencing symptoms of COVID-19 and continuing to adhere to all health precautionary measures.

Editorial Team Legacy

The legacy import form the old website to the new!

Editorial Team Legacy.

More from this writer

Join the conversation

Sign in to leave a comment. Every comment is reviewed before it goes live.

No comments yet. Start the conversation.